银屑病关节炎的达标治疗:方法与必要性
本文综述银屑病关节炎(PsA)达标治疗的证据与实施现状。2015年TICOPA随机对照试验证实达标治疗在关节炎和银屑病疾病活动度及患者报告疾病影响方面均有获益,但严格达标组严重不良事件发生率更高。欧洲及国际推荐支持达标治疗并使用最小疾病活动度(MDA)标准,然而常规实践中实施率低,真实世界数据显示治疗不足。
要点
- TICOPA试验证实PsA达标治疗可改善关节炎与银屑病活动度及患者报告结局。
- 严格达标组严重不良事件发生率高于常规治疗组。
- 欧洲及国际推荐支持达标治疗,常以MDA标准作为目标。
核心结论
- 达标治疗在PsA中具有临床获益证据并获得欧洲及国际推荐支持。
- 常规实践中达标治疗实施率低,真实世界数据显示治疗不足,需解决实施障碍。
研究设计与样本
- 本文为综述,围绕PsA达标治疗的方法与必要性展开论述。
- 核心证据来自2015年TICOPA随机对照试验。
主要发现
- TICOPA试验发现达标治疗在关节炎和银屑病疾病活动度及患者报告疾病影响方面均有获益。
- 分配至严格达标组的参与者严重不良事件发生率更高。
- 英国医生的定性研究帮助研究者理解了达标治疗实施的障碍。
关键数值与推荐
- 欧洲及国际推荐支持在PsA中使用达标治疗,并建议以最小疾病活动度(MDA)等结局指标指导实施。
临床怎么用
- 需解决达标治疗的实施障碍,为常规实践中的非专科医生提供教育与支持。
- 应促进优化治疗向临床转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With increasing recognition of the high burden and impact of psoriatic arthritis (PsA) and the growing number of therapeutic options, there has been an intensifying focus on treatment strategy in recent years. In 2015, the Tight Control of Psoriatic Arthritis study confirmed the clinical benefit of using a treat-to-target approach in PsA. This randomised controlled trial found benefits in both arthritis and psoriasis disease activity as well as lower disease impact reported by patients, although participants allocated to tight control experienced a higher rate of serious adverse events. European and international recommendations support the use of a treat-to-target approach in PsA and have offered specific advice on how to do this using outcomes such as the minimal disease activity criteria. However, implementation of this approach in routine practice is low, with real-world data highlighting undertreatment as a result. Recent qualitative work with physicians in the UK has helped researchers to understand the barriers to implementation of treat-to-target in PsA. We now need to address these barriers, provide education and support to non-specialist clinicians in routine practice, and aid the translation of optimal care to the clinic.
引用
- Dures E, Shepperd S, Mukherjee S, et al. Treat-to-target in PsA: methods and necessity. RMD Open. 2020. PMID: 32071281. doi:10.1136/rmdopen-2019-001083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。